In a longitudinal analysis of LPL FCS (n = 10) and non-LPL FCS (n = 2), over a median period of 44 months, D’Erasmo et al. observed relatively better control of hypertriglyceridaemia in non-LPL FCS, albeit the prevalence of AP and recurrence were similar [17]. This evidence concerns the gene LPL and hypertriglyceridemia.